ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Pre - HOPA News Dunp"
Episode Synopsis
A plethora of #oncopharm updates!
Isatuximab is approved and neratinib gets another breast cancer indication (2:00)
Pembrolizumab with chemo for triple-negative breast cancer (8:50)
New EPOC updated survival analysis on FOLFOX+cetuximab in isolated liver metastatic colon cancer (15:00)
Precision medicine in pancreatic cancer (19:30)
Cladribine + rituximab for hairy cell leukemia (23:30)
Isatuximab is approved and neratinib gets another breast cancer indication (2:00)
Pembrolizumab with chemo for triple-negative breast cancer (8:50)
New EPOC updated survival analysis on FOLFOX+cetuximab in isolated liver metastatic colon cancer (15:00)
Precision medicine in pancreatic cancer (19:30)
Cladribine + rituximab for hairy cell leukemia (23:30)
More episodes of the podcast OncoPharm
Bladder Cancer Updates & SC Amivantamab
18/12/2025
ASH 2025
11/12/2025
DPYD Deficiency Testing
04/12/2025
Cornucopia of Autumn Updates
26/11/2025
PGYNone: Dandelion Effect
20/11/2025
PGY1 Pathway: Road Trip!
13/11/2025
PGY2 Pathway: A Planned City
06/11/2025
Tale from the Crypt: Belantamab Mafodotin
30/10/2025
ESMO 2025
23/10/2025
IL-2
16/10/2025
In God we trust